文献速递免疫规划卫生政策与健康促进

ADVANCE系统测试:能否利用电子医疗数据开展安全性研究?以百日咳疫苗接种为例

ADVANCE system testing: Can safety studies be conducted using electronic healthcare data? An example using pertussis vaccination.
PubMed 文献 · Vaccine · 2019-10-31

ADVANCE公私合作项目旨在开发和测试利用欧洲医疗数据库进行疫苗快速效益-风险监测的系统,本研究为概念验证研究,评估该系统生成全细胞(wP)和无细胞(aP)百日咳疫苗相关风险发生率(IR)和发生率比(IRR)的可行性。结果显示估计的IR和IRR与已发表数据相当,表明ADVANCE系统能够合并多个欧洲医疗数据库评估wP和aP疫苗安全性数据。

要点

  • ADVANCE系统可合并多国电子医疗数据库评估百日咳疫苗安全性。
  • 估计的IR和IRR与已发表数据具有可比性。
  • 采用自身对照病例系列设计和随机效应Meta分析合并数据库特异性IRR。

核心结论

  • 估计的IR和IRR与已发表数据相当,表明ADVANCE系统能够合并多个欧洲医疗数据库评估wP和aP疫苗接种的安全性数据。

研究设计与样本

  • 数据来自丹麦2个医院数据库(AUH和SSI)及英国(THIN和RCGP RSC)、西班牙(SIDIAP和BIFAP)和意大利(Pedianet)的5个初级保健数据库。
  • 采用自身对照病例系列研究估计风险期与非风险期的数据库特异性IRR,并用随机效应Meta分析合并。

主要发现

  • 总体IR:发热在初级保健数据库为58.2(95%CI:58.1;58.3)、96.9(96.7;97.1),在医院数据库为8.56(8.5;8.6)。
  • 惊厥在初级保健数据库为7.6(95%CI:7.6;7.7)、3.55(3.5;3.6),在医院数据库为12.87(12.8;13)。
  • 持续哭闹在初级保健数据库为3.9(95%CI:3.8;3.9),注射部位反应为2.2(95%CI:2.1;2.2)。
  • 低张力低反应事件(HHE)在初级保健数据库为0.4(95%CI:0.4;0.4)、0.6(0.6;0.6),在医院数据库为0.2(0.2;0.3);嗜睡在初级保健数据库为0.3(95%CI:0.3;0.3)。
  • 调整年龄和健康疫苗接种者期后,所有剂次中wP疫苗接种后持续哭闹、发热和注射部位反应的合并IRR高于aP疫苗,惊厥的合并IRR低于aP疫苗。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The Accelerated Development of Vaccine benefit-risk Collaboration in Europe (ADVANCE) public-private collaboration, aimed to develop and test a system for rapid benefit-risk monitoring of vaccines using healthcare databases in Europe. The objective of this proof-of-concept (POC) study was to test the feasibility of the ADVANCE system to generate incidence rates (IRs) per 1000 person-years and incidence rate ratios (IRRs) for risks associated with whole cell- (wP) and acellular- (aP) pertussis vaccines, occurring in event-specific risk windows in children prior to their pre-school-entry booster. METHODS: The study population comprised almost 5.1 million children aged 1 month to <6 years vaccinated with wP or aP vaccines during the study period from 1 January 1990 to 31 December 2015. Data from two Danish hospital (H) databases (AUH and SSI) and five primary care (PC) databases from, UK (THIN and RCGP RSC), Spain (SIDIAP and BIFAP) and Italy (Pedianet) were analysed. Database-specific IRRs between risk vs. non-risk periods were estimated in a self-controlled case series study and pooled using random-effects meta-analyses. RESULTS: The overall IRs were: fever, 58.2 (95% CI: 58.1; 58.3), 96.9 (96.7; 97.1) for PC DBs and 8.56 (8.5; 8.6) for H DBs; convulsions, 7.6 (95% CI: 7.6; 7.7), 3.55 (3.5; 3.6) for PC and 12.87 (12.8; 13) for H; persistent crying, 3.9 (95% CI: 3.8; 3.9) for PC, injection-site reactions, 2.2 (95% CI 2.1; 2.2) for PC, hypotonic hypo-responsive episode (HHE), 0.4 (95% CI: 0.4; 0.4), 0.6 (0.6; 0.6) for PC and 0.2 (0.2; 0.3) for H; and somnolence: 0.3 (95% CI: 0.3; 0.3) for PC. The pooled IRRs for persistent crying, fever, and ISR, adjusted for age and healthy vaccinee period were higher after wP vs. aP vaccination, and lower for convulsions, for all doses. The IRR for HHE was slightly lower for wP than aP, while wP was associated with somnolence only for dose 1 and dose 3 compared with aP. CONCLUSIONS: The estimated IRs and IRRs were comparable with published data, therefore demonstrating that the ADVANCE system was able to combine several European healthcare databases to assess vaccine safety data for wP and aP vaccination.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Weibel D, Dodd C, Mahaux O, et al. ADVANCE system testing: Can safety studies be conducted using electronic healthcare data? An example using pertussis vaccination. Vaccine. 2019. PMID: 31677946. doi:10.1016/j.vaccine.2019.06.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。